BioHealth News Archive
Maryland Commercial Real Estate Services | Scheer Partners
(Rockville, MD – August 20, 2020) - Scheer Partners is proud to announce that 704 Quince Orchard Road, Gaithersburg, Maryland is 100% leased. In…
Read More
Adaptive Phage Therapeutics Announces Mayo Clinic as Lead Investor in Convertible Note Financing – BioHealth Capital Region
GAITHERSBURG, Md.–(BUSINESS WIRE)–Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant…
Read More
Register now for Women Building Bio 2020
Women Building Bio is where the vision is transformed into reality. Women advancing the industry with all stakeholders, men and women, front and center…
Read More
Nose is a key entryway for coronavirus, Hopkins study shows – Baltimore Sun
The cells that allow people to smell are a key entryway for the coronavirus, making nose coverings crucial, suggests new research from the Johns…
Read More
Apply for funding under the NIAID New Innovators Award (DP2) – MIDAS
The National Institute of Allergy and Infectious Diseases (NIAID) recently reissued the funding opportunity announcement (FOA) for the New Innovators Award (PAR-20-259). The first…
Read MoreSweden to have 18m vaccine doses next year: vaccine coordinator – The Local
Sweden expects to have as many as 18m doses of coronavirus vaccine by next year, enough to inoculate the entire Swedish population, according to…
Read More
University System of Maryland Rolls Out Virtual Science Labs Across All Campuses — Campus Technology
The University System of Maryland has partnered with Labster to provide its virtual laboratory simulations across all USM institutions. The university is working to…
Read More
Emergent BioSolutions Announces FDA Approval of NARCAN® (naloxone HCl) Nasal Spray Shelf Life Extension to 36 Months NYSE:EBS
GAITHERSBURG, Md., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has…
Read More
Precigen Announces First Patient Dosed in Phase I/II Study of First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-associated Cancers | BioSpace
GERMANTOWN, Md., Aug. 17, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to…
Read More
United Therapeutics Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Tyvaso® For Pulmonary Hypertension Associated With Interstitial Lung Disease | BioSpace
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food…
Read MoreFrancis Collins Relies on Science and Faith – WSJ
It takes no time for Francis Collins, the director of the National Institutes of Health, to recall the moment when he knew he wanted…
Read More
2020 Technology Showcase (NCI)
The 2020 Technology Showcase is going virtual! Reserve the afternoon of September 9th on your calendar for the 2020 Technology Showcase. The 4th annual event will…
Read More
Register Now! 2020 BioHealth Capital Region Forum
This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, Virginia Bio, Children’s National Health System, Johns Hopkins…
Read More
Sign Up Now – August 26th EIR Feedback Session
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your complimentary…
Read More
Kite, a Gilead Company, Looks to Expand Its Cell Therapy Maryland Operations | BioSpace
Maryland has become a key part of the strategy for Kite, a Gilead company, and its mission to find a cure for cancer. As…
Read More